News

Laurent Pharmaceuticals Joins Battle Against COVID-19

9 April 2020

Laurent Pharmaceuticals Inc., a clinical-stage biopharmaceutical company that spun off from McGill University in 2012, today announces that it is planning...

Read More

Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

4 December 2019

Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval...

Read More

EVENTS

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA
read more
Laurent Pharma to participate to BIO International Convention,  June 3-6 2024, San Diego, CA, USA
read more

Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA

read more
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
read more
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022
read more